Skip to main content

Table 1 Baseline demographic of HIV-positive MSM screened

From: Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM)

Variables

HIV-MSM patients n = 162

Mean age; years ±SD

37.9 ± 10.2

Spanish, n (%)

153 (94.2)

Primary school, n (%)

21 (13)

Secondary school; technical school, n (%)

53 (32.7)

University, n (%)

88 (54.3)

Median months of sexual activity (P25–P75)

216 (120–300)

Median of anal-receptive sexual partners in previous 12 months (P25–P75)

1 (1–5)

Overall median number of sexual partners, (P25–P75)

70 (20–250)

Condom users, n (%)

127 (78.4)

Median percentage of condom use, (P25–P75)

100% (50–100%)

History of condylomatosis, n (%)

47 (29)

Current condylomatosis, n (%)

48 (29.6)

Syphilis treated, n (%)

35 (21.6)

Latent treated tuberculosis, n (%)

10 (11.8)

Chronic HCV infection, n (%)

4 (4.7)

Chronic HBV infection, n (%)

1 (1.2)

Smoking habit, n (%)

33 (38.8)

Ex-smoker, n (%)

12 (14.1)

Ex-IVDA, n (%)

1 (1.2)

Alcohol, median SUA, (P25–P75)

1 (0–1)

Prior AIDS diagnosis, n (%), 95% CI

27.8 (45)

Median time of HIV duration, months (P25–P75)

57 (24.5–120)

CD4 nadir, cells/µL, (±SD)

337.8 (±205)

Treatment naïve, n (%)

14 (8.6)

Median ART, months (P25–P75)

37 (13–88)

Median lines of ART, n (P25–P75)

1 (1–2)

Virological failure, n (%), 95% CI

5 (3.3)

Baseline CD4, cells/µL (±SD)

688 (±256.4)

Baseline CD8, cells/µL (±SD)

976.5 (±399.4)

Baseline viral load, log10 (±SD)

3.74 (±4.5)

  1. HCV hepatitis C virus, HBV hepatitis B virus, LSIL low-squamous intra-epithelial lesion, HSIL high-squamous intra-epithelial lesion, ASC indeterminate lesion, HPV human papilloma virus, SUA standard unit of alcohol, Ex-IVDA ex-intravenous drug abuser, HR-HPV high risk HPV, LR-HPV low risk HPV, SD standard deviation, IQR interquartile range